Company / Net Income
Zoetis Net Income History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Net Income
$2.7B
FY2025
5-year range
$1.5B / $2.7B
FY2021-FY2025
Trend
+7.5%
vs FY2024
Sector context
#13 of 216
Health Care
What the data says
Among 216 Health Care companies, Zoetis is in the top 6% for net income. Net Income has increased for 5 consecutive years, from $1.4B in FY2020 to $2.7B in FY2025.
Based on SEC 10-K filings.
$2.7B in FY2025 with a 5-year CAGR of +13.4%. Top quartile in the Health Care sector.
Improved from $2.0B to $2.7B over the past 2 years.
Health Care sector context is included.
Net Income over time
Growth rates
- 3-Year CAGR
- +17.7%
- 5-Year CAGR
- +13.4%
- 10-Year CAGR
- -
Sector benchmark
Top 6% in Health CareTop 6% of 216This company $2.7B Sector average $454.3M
▼
+488.4% above sector average
Key checks
Key Insights
- Zoetis's net income has grown for 5 consecutive years.
- 5-year CAGR of +13.4%, indicating consistent growth.
- In FY2025, net income increased 7.5% year-over-year.
- Ranks #13 out of 216 companies in the Health Care sector.
Company context
Key Data Points
- Strong profit margin: 28.2%
- Strong return on equity: 49.1%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Net IncomeValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $2.7B | +7.5% |
| FY2024 | $2.5B | +22.0% |
| FY2023 | $2.0B | +24.4% |
| FY2022 | $1.6B | +9.2% |
| FY2021 | $1.5B | +5.0% |
| FY2020 | $1.4B | -4.8% |
| FY2019 | $1.5B | +5.0% |
| FY2018 | $1.4B | +321.2% |
| FY2017 | $339.0M | -41.9% |
| FY2016 | $583.0M | +15.7% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026